Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Acta Orthopaedica|July 26, 2021
30-day and 1-year mortality after skeletal fractures: a register study of 295,713 fractures at different locationsCamilla Bergh, Michael Möller, Jan Ekelund, et al.
International Journal of Colorectal Disease|June 22, 2014
Extralevator abdominoperineal excision (ELAPE) for rectal cancer--short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warrantedMattias Prytz, Eva Angenete, Jan Ekelund, et al.
Laryngoscope Investigative Otolaryngology|April 18, 2022
Voice rest after vocal fold polyp surgery: A Swedish register study of 588 patientsGunnar Björck, Stellan Hertegård, Jan Ekelund, et al.
The Bone & Joint Journal|November 2, 2020
Mortality after a proximal humeral fractureCarl Bergdahl, David Wennergren, Jan Ekelund, et al.
Journal of Clinical Medicine|May 14, 2022
Mortality after Sustaining Skeletal Fractures in Relation to AgeCamilla Bergh, Michael Möller, Jan Ekelund, et al.
The Bone & Joint Journal|September 14, 2020
Mortality after a proximal humeral fractureCarl Bergdahl, David Wennergren, Jan Ekelund, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 25, 2015
Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapyBjörn Ställberg, Ian Naya, Jan Ekelund, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 30, 2020
Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide SurveyAnn-Marie Svensson, Jan Ekelund, Mervete Miftaraj, et al.
BMC Musculoskeletal Disorders|October 16, 2024
Non-surgical treatment of lateral malleolar fractures is safe: long-term follow-up of a comprehensive treatment algorithmErik Börjesson, Karolina Johannesson, Jan Ekelund, et al.
Journal of Diabetes Investigation|August 26, 2016
Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trialYukiko Onishi, Kenichi Yamada, Jeppe Zacho, et al.
Pageof 6